Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
Open Access
- 26 November 2002
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 16 (12) , 2423-2428
- https://doi.org/10.1038/sj.leu.2402712
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Donor leukocyte infusions in acute lymphocytic leukemiaBone Marrow Transplantation, 2000
- Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de Moelle (SFGM)British Journal of Haematology, 2000
- Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograftBone Marrow Transplantation, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Journal of Clinical Oncology, 1998
- Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemiaBone Marrow Transplantation, 1998
- Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.Journal of Clinical Oncology, 1993
- Chronic graft-versus-host syndrome in manThe American Journal of Medicine, 1980
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974